Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Ann Oncol ; 32(12): 1608-1617, 2021 12.
Article de Anglais | MEDLINE | ID: mdl-34690007

RÉSUMÉ

BACKGROUND: In glioma, TERT promoter mutation and loss of ATRX (ATRX loss) are associated with reactivation of telomerase or alternative lengthening of telomeres (ALT), respectively, i.e. the two telomere maintenance mechanisms (TMM). Strangely, 25% of gliomas have been reported to display neither or both of these alterations. MATERIALS AND METHODS: The C-circle (CC) assay was adapted to tumor (formalin-fixed paraffin-embedded and frozen) and blood samples to investigate the TMM. RESULTS: We constructed a CC-based algorithm able to identify the TMM and reported a sensitivity of 100% and a specificity of 97.3% (n = 284 gliomas). By combining the TMM, the mutational status of the isocitrate dehydrogenase 1/2 (IDH) gene (IDHmt), and the histological grading, we propose a new classification tool: TeloDIAG. This classification defined five subtypes: tOD, tLGA, tGBM_IDHmt, tGBM, and tAIV, corresponding to oligodendroglioma, IDHmt low-grade astrocytoma, IDHmt glioblastoma, and IDHwt glioblastoma (GBM), respectively; the last class gathers ALT+ IDHwt gliomas that tend to be related to longer survival (21.2 months) than tGBM (16.5 months). The TeloDIAG was 99% concordant with the World Health Organization classification (n = 312), and further modified the classification of 55 of 144 (38%) gliomas with atypical molecular characteristics. As an example, 14 of 69 (20%) of TERTwt, ATRXwt, and IDHwt GBM were actually tAIV. Outstandingly, CC in blood sampled from IDHmt astrocytoma patients was detected with a sensitivity of 56% and a specificity of 97% (n = 206 gliomas and 30 healthy donors). CONCLUSION: The TeloDIAG is a new, simple, and effective tool helping in glioma diagnosis and a promising option for liquid biopsy.


Sujet(s)
Tumeurs du cerveau , Gliome , Tumeurs du cerveau/diagnostic , Tumeurs du cerveau/génétique , Gliome/diagnostic , Gliome/génétique , Humains , Isocitrate dehydrogenases/génétique , Biopsie liquide , Télomère/génétique , Protéine nucléaire liée à l'X/génétique
2.
J Virol ; 84(1): 503-15, 2010 Jan.
Article de Anglais | MEDLINE | ID: mdl-19828619

RÉSUMÉ

Membrane targeting of the human immunodeficiency virus Gag proteins is dependent on phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P(2)] located in the plasma membrane. In order to determine if evolutionarily distant retroviral Gag proteins are targeted by a similar mechanism, we generated mutants of the matrix (MA) domain of murine leukemia virus (MuLV) Gag, examined their binding to membrane models in vitro, and analyzed their phenotypes in cell culture. In vitro, we showed that MA bound all the phosphatidylinositol phosphates with significant affinity but displayed a strong specificity for PI(4,5)P(2) only if enhanced by phosphatidylserine. Mutations in the polybasic region in MA dramatically reduced this affinity. In cells, virus production was strongly impaired by PI(4,5)P(2) depletion under conditions of 5ptaseIV overexpression, and mutations in the MA polybasic region altered Gag localization, membrane binding, and virion production. Our results suggest that the N-terminal polybasic cluster of MA is essential for Gag targeting to the plasma membrane. The binding of the MA domain to PI(4,5)P(2) appears to be a conserved feature among retroviruses despite the fact that the MuLV-MA domain is structurally different from that of human immunodeficiency virus types 1 and 2 and lacks a readily identifiable PI(4,5)P(2) binding cleft.


Sujet(s)
Membrane cellulaire/composition chimique , Produits du gène gag/métabolisme , Virus de la leucémie murine/physiologie , Phosphatidylinositol diphosphate-4,5/métabolisme , Sites de fixation , Produits du gène gag/génétique , Mutagenèse , Phosphatidylsérine , Retroviridae , Réplication virale
3.
Nouv Presse Med ; 9(38): 2823-7, 1980 Oct 18.
Article de Français | MEDLINE | ID: mdl-7443406

RÉSUMÉ

Thirty six cases of traumatic rupture of the thoracic aorta (TRA) were diagnosed during the hours following the accident responsible. Rupture was situated at the aortic isthmus in 32 cases, the ascending aortic in 2 cases, the arch of the aorta in 1 case and the descending sub-isthmic aorta in 1 case. Ten patients had no rib fractures. In 16 patients not undergoing surgery before 20th hour after the trauma, 10 died of secondary rupture. The course of a TRA is thus unpredictable and it is of fundamental importance to make the diagnosis and undertake appropriate surgical treatment immediately. The essential clinical sign is a difference in blood pressure between the upper and lower limbs (6 6%). Radiological signs suggestive of TRA are, in a plain PA chest film : widening of the mediastinum (92 %), poor visibility of the knuckle of the aorta (89 %), left haemothorax (67 %), deviation of the trachea to the right (55 %) and lowering of the left main bronchus (47 %). The slightest suspicion of a TRA should lead to aortic angiography preferably via an arterial approach (humeral or femoral), or intravenously. Surgical treatment should not be delayed.


Sujet(s)
Aorte thoracique/traumatismes , Rupture aortique/diagnostic , Rupture aortique/étiologie , Rupture aortique/anatomopathologie , Aortographie , Femelle , Humains , Poumon/imagerie diagnostique , Mâle
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE